BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10493987)

  • 1. Bone marrow transplantation in a Hunter patient with P266H mutation.
    Coppa GV; Gabrielli O; Cordiali R; Villani GR; Di Natale P
    Int J Mol Med; 1999 Oct; 4(4):433-6. PubMed ID: 10493987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation.
    Li P; Thompson JN; Hug G; Huffman P; Chuck G
    Am J Med Genet; 1996 Sep; 64(4):531-5. PubMed ID: 8870917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
    Karsten S; Voskoboeva E; Tishkanina S; Pettersson U; Krasnopolskaja X; Bondeson ML
    Hum Genet; 1998 Dec; 103(6):732-5. PubMed ID: 9921913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of four novel mutations in the iduronate-2-sulfatase gene. Mutations in brief no. 123. Online.
    Balzano N; Villani GR; Grosso M; Izzo P; Di Natale P
    Hum Mutat; 1998; 11(4):333. PubMed ID: 10215411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 38.8 kb deletion mutation of the iduronate-2-sulfatase gene in a patient with Hunter syndrome.
    Chou YY; Chao SC; Kuo PL; Lin SJ
    J Formos Med Assoc; 2005 Apr; 104(4):273-5. PubMed ID: 15909065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 9 novel IDS gene mutations in 19 unrelated Hunter syndrome (mucopolysaccharidosis Type II) patients. Mutations in brief no. 202. Online.
    Karsten SL; Voskoboeva E; Carlberg BM; Kleijer WJ; Tsnnesen T; Pettersson U; Bondeson ML
    Hum Mutat; 1998; 12(6):433. PubMed ID: 10671065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type II in females and response to enzyme replacement therapy.
    Jurecka A; Krumina Z; Żuber Z; Różdżyńska-Świątkowska A; Kłoska A; Czartoryska B; Tylki-Szymańska A
    Am J Med Genet A; 2012 Feb; 158A(2):450-4. PubMed ID: 22246721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.
    Sukegawa-Hayasaka K; Kato Z; Nakamura H; Tomatsu S; Fukao T; Kuwata K; Orii T; Kondo N
    J Inherit Metab Dis; 2006 Dec; 29(6):755-61. PubMed ID: 17091340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation.
    Lonardo F; Di Natale P; Lualdi S; Acquaviva F; Cuoco C; Scarano F; Maioli M; Pavone LM; Di Gregorio G; Filocamo M; Scarano G
    Am J Med Genet A; 2014 Oct; 164A(10):2627-32. PubMed ID: 25044788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
    Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hunter Syndrome in Northern India: Clinical features and Mutation Spectrum.
    Narayanan DL; Srivastava P; Mandal K; Gambhir PS; Phadke SR
    Indian Pediatr; 2016 Feb; 53(2):134-6. PubMed ID: 26897145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
    Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
    BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II.
    Bonuccelli G; Di Natale P; Corsolini F; Villani G; Regis S; Filocamo M
    Biochim Biophys Acta; 2001 Nov; 1537(3):233-8. PubMed ID: 11731225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.
    Kim CH; Hwang HZ; Song SM; Paik KH; Kwon EK; Moon KB; Yoon JH; Han CK; Jin DK
    Hum Mutat; 2003 Apr; 21(4):449-50. PubMed ID: 12655569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome.
    Bondeson ML; Malmgren H; Dahl N; Carlberg BM; Pettersson U
    Eur J Hum Genet; 1995; 3(4):219-27. PubMed ID: 8528670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.